1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The (CSR)FENCE Score

BACKGROUND: Prediction of febrile neutropenia (FN) with initiation of preventive measures in high-risk populations may lead to better outcomes in cancer treatment. We have previously developed a score to predict FN in the first cycle of chemotherapy.(1) We aimed to develop and validate a cycle-speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Aagaard, Theis, Reekie, Joanne, Roen, Ashley, Daugaard, Gedske, Sengeløv, Henrik, Specht, Lena, Mocroft, Amanda, Lundgren, Jens, Helleberg, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253517/
http://dx.doi.org/10.1093/ofid/ofy210.1377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253517/
http://dx.doi.org/10.1093/ofid/ofy210.1377

Ejemplares similares